Showing results (111-120 of 209) with videos related to

Sort By:
Pageof 21
Plos One|August 17, 2013
Identification and validation of a multigene predictor of recurrence in primary laryngeal cancerElena Fountzilas, Vassiliki Kotoula, Nikolaos Angouridakis, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast CancerFranziska M Würfel, Ralph M Wirtz, Christoph Winterhalter, et al.
British Journal of Cancer|January 31, 2018
Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancerKaren Legler, Ricarda Rosprim, Tosca Karius, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2009
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trialJulia M Hofstra, Amanda J W Branten, Joris J J M Wirtz, et al.
Cancers|October 2, 2020
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with PrognosisJennifer Kubon, Danijel Sikic, Markus Eckstein, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|September 9, 2014
[Turnover of Non-medical Staff in Outpatient Oncology Practices: Is Building Social Capital a Solution?]T D Gloede, N Ernstmann, W Baumann, et al.
Scientific Reports|September 28, 2018
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-makingThomas S Worst, Cleo-Aron Weis, Robert Stöhr, et al.
World Neurosurgery|July 21, 2020
Utility of P2Y12 Reactive Unit Assessment on Ticagrelor in Cerebral Aneurysms Treated with Intracranial Stenting and Flow Diversion: Cohort Study and Case Report From Two Neurovascular CentersChristian O Bohan, Mirja M Wirtz, Philipp Hendrix, et al.
Virchows Archiv : an International Journal of Pathology|August 13, 2016
ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)Johannes Breyer, Ralph M Wirtz, Mark Laible, et al.
BJU International|August 19, 2018
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancerJohannes Breyer, Ralph M Wirtz, Philipp Erben, et al.
Pageof 21